{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:06:55Z","timestamp":1770332815187,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18059186"],"award-info":[{"award-number":["18059186"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18059186"],"award-info":[{"award-number":["18059186"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18059186"],"award-info":[{"award-number":["18059186"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35835-5","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T11:25:13Z","timestamp":1768303513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical significance of guideline-directed medical therapy in acute heart failure with reduced or mildly reduced ejection fraction"],"prefix":"10.1038","volume":"16","author":[{"given":"Yutaro","family":"Miyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neiko","family":"Ozasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Yaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yodo","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritake","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"35835_CR1","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"Effects of enalapril on","year":"1987","unstructured":"Effects of enalapril on. Mortality in severe congestive heart failure. Results of the cooperative North Scandinavian Enalapril survival study (CONSENSUS). N Engl. J. Med. 316, 1429\u20131435 (1987).","journal-title":"N Engl. J. Med."},{"key":"35835_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl. J. Med. 341, 709\u2013717 (1999).","journal-title":"N Engl. J. Med."},{"key":"35835_CR3","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","author":"M Packer","year":"2002","unstructured":"Packer, M. et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106, 2194\u20132199 (2002).","journal-title":"Circulation"},{"key":"35835_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray, J. J. et al. Angiotensin-neprilysin Inhibition versus Enalapril in heart failure. N Engl. J. Med. 371, 993\u20131004 (2014).","journal-title":"N Engl. J. Med."},{"key":"35835_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray, J. J. V. et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl. J. Med. 381, 1995\u20132008 (2019).","journal-title":"N Engl. J. Med."},{"key":"35835_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/ejhf.932","volume":"20","author":"E Gayat","year":"2018","unstructured":"Gayat, E. et al. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: A propensity-score matched study. Eur. J. Heart Fail. 20, 345\u2013354 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"35835_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599\u20133726 (2021).","journal-title":"Eur. Heart J."},{"key":"35835_CR8","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh, T. A. et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 44, 3627\u20133639 (2023).","journal-title":"Eur. Heart J."},{"key":"35835_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene, S. J. et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J. Am. Coll. Cardiol. 72, 351\u2013366 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"35835_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jchf.2018.10.010","volume":"7","author":"HP Brunner-La Rocca","year":"2019","unstructured":"Brunner-La Rocca, H. P. et al. Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF registry. JACC Heart Fail. 7, 13\u201321 (2019).","journal-title":"JACC Heart Fail."},{"key":"35835_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10741-023-10325-2","volume":"28","author":"J Malgie","year":"2023","unstructured":"Malgie, J., Clephas, P. R. D., Brunner-La Rocca, H. P., de Boer, R. A. & Brugts, J. J. Guideline-directed medical therapy for hfref: sequencing strategies and barriers for life-saving drug therapy. Heart Fail. Rev. 28, 1221\u20131234 (2023).","journal-title":"Heart Fail. Rev."},{"key":"35835_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ejhf.3267","volume":"26","author":"J Malgie","year":"2024","unstructured":"Malgie, J. et al. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: first data from the TITRATE-HF study. Eur. J. Heart Fail. 26, 1549\u20131560 (2024).","journal-title":"Eur. J. Heart Fail."},{"key":"35835_CR13","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jchf.2024.08.002","volume":"12","author":"SJ Greene","year":"2024","unstructured":"Greene, S. J. et al. Physician-reported reasons for not initiating guideline-directed medical therapy for heart failure. JACC Heart Fail. 12, 2120\u20132122 (2024).","journal-title":"JACC Heart Fail."},{"key":"35835_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cardfail.2021.08.024","volume":"28","author":"V Sundaram","year":"2022","unstructured":"Sundaram, V. et al. Hospitalization for heart failure in the united States, UK, Taiwan, and japan: an international comparison of administrative health records on 413,385 individual patients. J. Card Fail. 28, 353\u2013366 (2022).","journal-title":"J. Card Fail."},{"key":"35835_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ehf2.12138","volume":"4","author":"E Yamamoto","year":"2017","unstructured":"Yamamoto, E. et al. Kyoto congestive heart failure (KCHF) study: rationale and design. ESC Heart Fail. 4, 216\u2013223 (2017).","journal-title":"ESC Heart Fail."},{"key":"35835_CR16","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1253\/circj.CJ-17-1386","volume":"82","author":"H Yaku","year":"2018","unstructured":"Yaku, H. et al. Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in japan\u3000- observations from the prospective, multicenter Kyoto congestive heart failure (KCHF) registry. Circ. J. 82, 2811\u20132819 (2018).","journal-title":"Circ. J."},{"key":"35835_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ejhf.1149","volume":"20","author":"LH Lund","year":"2018","unstructured":"Lund, L. H. et al. Heart failure with mid-range ejection fraction in charm: Characteristics, outcomes and effect of Candesartan across the entire ejection fraction spectrum. Eur. J. Heart Fail. 20, 1230\u20131239 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"35835_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ejhf.807","volume":"19","author":"K Tsuji","year":"2017","unstructured":"Tsuji, K. et al. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 study. Eur. J. Heart Fail. 19, 1258\u20131269 (2017).","journal-title":"Eur. J. Heart Fail."},{"key":"35835_CR19","doi-asserted-by":"publisher","first-page":"e195892","DOI":"10.1001\/jamanetworkopen.2019.5892","volume":"2","author":"H Yaku","year":"2019","unstructured":"Yaku, H. et al. Association of mineralocorticoid receptor antagonist use with all-cause mortality and hospital readmission in older adults with acute decompensated heart failure. JAMA Netw. Open. 2, e195892 (2019).","journal-title":"JAMA Netw. Open."},{"key":"35835_CR20","doi-asserted-by":"publisher","first-page":"e0239100","DOI":"10.1371\/journal.pone.0239100","volume":"15","author":"Y Yoshikawa","year":"2020","unstructured":"Yoshikawa, Y. et al. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: from the KCHF registry. PloS One. 15, e0239100 (2020).","journal-title":"PloS One"},{"key":"35835_CR21","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa, A. et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. Lancet 400, 1938\u20131952 (2022).","journal-title":"Lancet"},{"key":"35835_CR22","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1253\/circj.CJ-24-1020","volume":"89","author":"Y Fujimoto","year":"2025","unstructured":"Fujimoto, Y. et al. Contemporary guideline-directed medical therapy and outpatient worsening heart failure events in hospitalized patients with heart failure\u3000- preliminary observational study on utilizing predischarge period for optimizing medications in hospitalized patients with heart failure (PRE-UPFRONT-HF). Circ. J. 89, 912\u2013920 (2025).","journal-title":"Circ. J."},{"key":"35835_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur. Heart J. Cardiovasc. Imaging. 16, 233\u2013270 (2015).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"35835_CR24","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1093\/eurheartj\/ehae561","volume":"45","author":"A Tanaka","year":"2024","unstructured":"Tanaka, A. et al. In-hospital initiation of angiotensin receptor-neprilysin Inhibition in acute heart failure: the PREMIER trial. Eur. Heart J. 45, 4482\u20134493 (2024).","journal-title":"Eur. Heart J."},{"key":"35835_CR25","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/ejhf.2722","volume":"24","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril\/valsartan. Eur. J. Heart Fail. 24, 2307\u20132319 (2022).","journal-title":"Eur. J. Heart Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35835-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35835-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35835-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:48:55Z","timestamp":1770288535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35835-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35835-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5116"}}